Shenzhen Mindray Valuation
| 300760 Stock | 260.01 9.05 3.36% |
At this time, the company appears to be overvalued. Shenzhen Mindray Bio has a current Real Value of USD227.27 per share. The regular price of the company is USD260.01. Our model measures the value of Shenzhen Mindray Bio from inspecting the company fundamentals such as Shares Outstanding of 1.21 B, return on equity of 0.32, and Operating Margin of 0.43 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 8.7944 | Enterprise Value 308.9 B | Enterprise Value Ebitda 22.252 | Price Sales 8.4864 | Forward PE 22.2222 |
Overvalued
Today
Please note that Shenzhen Mindray's price fluctuation is very steady at this time. Calculation of the real value of Shenzhen Mindray Bio is based on 3 months time horizon. Increasing Shenzhen Mindray's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shenzhen Mindray is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shenzhen Stock. However, Shenzhen Mindray's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 260.01 | Real 227.27 | Hype 269.63 |
The real value of Shenzhen Stock, also known as its intrinsic value, is the underlying worth of Shenzhen Mindray Bio Company, which is reflected in its stock price. It is based on Shenzhen Mindray's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shenzhen Mindray's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shenzhen Mindray Bio Medical helps investors to forecast how Shenzhen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shenzhen Mindray more accurately as focusing exclusively on Shenzhen Mindray's fundamentals will not take into account other important factors: Shenzhen Mindray Cash |
|
Shenzhen Mindray Total Value Analysis
Shenzhen Mindray Bio Medical is presently forecasted to have takeover price of 308.86 B with market capitalization of 314.62 B, debt of 7.75 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shenzhen Mindray fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
308.86 B | 314.62 B | 7.75 M |
Shenzhen Mindray Investor Information
About 57.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 10.22. Shenzhen Mindray Bio last dividend was issued on the 7th of November 2024. Based on the key measurements obtained from Shenzhen Mindray's financial statements, Shenzhen Mindray Bio Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 7.1 B | 11.1 B |
|
| |||||
| Operating Income | 6.7 B | 12.9 B |
|
|
Shenzhen Mindray Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shenzhen Mindray has an asset utilization ratio of 72.87 percent. This suggests that the Company is making USD0.73 for each dollar of assets. An increasing asset utilization means that Shenzhen Mindray Bio Medical is more efficient with each dollar of assets it utilizes for everyday operations.Shenzhen Mindray Ownership Allocation
Shenzhen Mindray Bio shows a total of 1.21 Billion outstanding shares. Shenzhen Mindray Bio maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Shenzhen Mindray Profitability Analysis
The company reported the revenue of 34.93 B. Net Income was 11.58 B with profit before overhead, payroll, taxes, and interest of 19.48 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shenzhen Mindray's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shenzhen Mindray and how it compares across the competition.
About Shenzhen Mindray Valuation
The stock valuation mechanism determines Shenzhen Mindray's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shenzhen Mindray. We calculate exposure to Shenzhen Mindray's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shenzhen Mindray's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 23.1 B | 13.6 B |
Shenzhen Mindray Quarterly Retained Earnings |
|
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Mindray's price analysis, check to measure Shenzhen Mindray's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Mindray is operating at the current time. Most of Shenzhen Mindray's value examination focuses on studying past and present price action to predict the probability of Shenzhen Mindray's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Mindray's price. Additionally, you may evaluate how the addition of Shenzhen Mindray to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |